CD40LG and COVID-19: To fill this gap and to increase the sensitivity of COVID-19 diagnoses, Xie et al. used both commercial IgM–IgG immunoassay and nucleic acid assay for detection and tested this combination with 56 patients with suspected SARS‐CoV‐2 infection.27